Metabolic memory underlying minimal residual disease in breast cancer.
cam.issuedOnline | 2021-10-25 | |
dc.contributor.author | Radic Shechter, Ksenija | |
dc.contributor.author | Kafkia, Eleni | |
dc.contributor.author | Zirngibl, Katharina | |
dc.contributor.author | Gawrzak, Sylwia | |
dc.contributor.author | Alladin, Ashna | |
dc.contributor.author | Machado, Daniel | |
dc.contributor.author | Lüchtenborg, Christian | |
dc.contributor.author | Sévin, Daniel C | |
dc.contributor.author | Brügger, Britta | |
dc.contributor.author | Patil, Kiran R | |
dc.contributor.author | Jechlinger, Martin | |
dc.contributor.orcid | Radic Shechter, Ksenija [0000-0003-3139-9184] | |
dc.contributor.orcid | Zirngibl, Katharina [0000-0002-7518-0339] | |
dc.contributor.orcid | Gawrzak, Sylwia [0000-0002-7047-3319] | |
dc.contributor.orcid | Machado, Daniel [0000-0002-2063-5383] | |
dc.contributor.orcid | Patil, Kiran R [0000-0002-6166-8640] | |
dc.contributor.orcid | Jechlinger, Martin [0000-0002-3710-4466] | |
dc.date.accessioned | 2022-01-06T11:50:08Z | |
dc.date.available | 2022-01-06T11:50:08Z | |
dc.date.issued | 2021-10 | |
dc.date.updated | 2022-01-06T11:50:07Z | |
dc.description | Funder: European Molecular Biology Laboratory | |
dc.description | Funder: European Molecular Biology Laboratory (EMBL) | |
dc.description.abstract | Tumor relapse from treatment-resistant cells (minimal residual disease, MRD) underlies most breast cancer-related deaths. Yet, the molecular characteristics defining their malignancy have largely remained elusive. Here, we integrated multi-omics data from a tractable organoid system with a metabolic modeling approach to uncover the metabolic and regulatory idiosyncrasies of the MRD. We find that the resistant cells, despite their non-proliferative phenotype and the absence of oncogenic signaling, feature increased glycolysis and activity of certain urea cycle enzyme reminiscent of the tumor. This metabolic distinctiveness was also evident in a mouse model and in transcriptomic data from patients following neo-adjuvant therapy. We further identified a marked similarity in DNA methylation profiles between tumor and residual cells. Taken together, our data reveal a metabolic and epigenetic memory of the treatment-resistant cells. We further demonstrate that the memorized elevated glycolysis in MRD is crucial for their survival and can be targeted using a small-molecule inhibitor without impacting normal cells. The metabolic aberrances of MRD thus offer new therapeutic opportunities for post-treatment care to prevent breast tumor recurrence. | |
dc.identifier.doi | 10.17863/CAM.79595 | |
dc.identifier.eissn | 1744-4292 | |
dc.identifier.issn | 1744-4292 | |
dc.identifier.other | PMC8543468 | |
dc.identifier.other | 34694069 | |
dc.identifier.uri | https://www.repository.cam.ac.uk/handle/1810/332149 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | Springer Science and Business Media LLC | |
dc.publisher.url | http://dx.doi.org/10.15252/msb.202010141 | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.source | essn: 1744-4292 | |
dc.source | nlmid: 101235389 | |
dc.subject | glycolysis | |
dc.subject | metabolic modeling | |
dc.subject | multi-omics integration | |
dc.subject | oncogenic memory | |
dc.subject | organoids | |
dc.subject | Animals | |
dc.subject | Breast Neoplasms | |
dc.subject | Female | |
dc.subject | Humans | |
dc.subject | Mice | |
dc.subject | Neoplasm Recurrence, Local | |
dc.subject | Neoplasm, Residual | |
dc.title | Metabolic memory underlying minimal residual disease in breast cancer. | |
dc.type | Article | |
dcterms.dateAccepted | 2021-09-29 | |
prism.issueIdentifier | 10 | |
prism.publicationName | Mol Syst Biol | |
prism.volume | 17 | |
pubs.funder-project-id | EC | H2020 | H2020 Priority Excellent Science | H2020 Marie Skodowska-Curie Actions (MSCA) (664726) | |
pubs.funder-project-id | Marie Curie (Marie Curie Cancer Care) (PCIG-GA--2011-294121) | |
pubs.funder-project-id | Deutsche Forschungsgemeinschaft (DFG) (331351713 - SFB1324, 112927078 - TRR83) | |
pubs.funder-project-id | Marie Curie (PCIG‐GA‐‐2011‐294121) | |
pubs.funder-project-id | UKRI | Medical Research Council (MRC) (MC_UU_00025/11) | |
pubs.funder-project-id | Medical Research Council (MC_UU_00025/11) | |
pubs.funder-project-id | Deutsche Forschungsgemeinschaft (112927078 ‐ TRR83, 331351713 ‐ SFB1324) | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0/ | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.15252/msb.202010141 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- article.pdf
- Size:
- 2.98 MB
- Format:
- Adobe Portable Document Format
- Description:
- Published version
- Licence
- https://creativecommons.org/licenses/by/4.0/